TrialJournal of hematology & oncology2025

A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias.

Jayastu Senapati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.